SCHEDULE: T. Rowe Price Trims Globant SA Stake to 4.4%
Beneficial Ownership Report
T. Rowe Price Associates, Inc. has reported a reduced beneficial ownership stake of 4.4% in Globant SA common stock.
Summary
- T. Rowe Price Associates, Inc., an investment adviser, filed an Amendment No. 7 to its Schedule 13G regarding its beneficial ownership in Globant SA.
- The filing indicates T. Rowe Price Associates, Inc. beneficially owns 1,947,561 shares of Globant SA common stock.
- This represents 4.4% of the total outstanding common stock of Globant SA.
- The reporting person holds sole voting power over 1,881,780 shares and sole dispositive power over 1,938,382 shares.
- The CUSIP number for Globant SA common stock is L44385109.
- Globant SA's principal executive offices are located at 37A Avenue J.F. Kennedy, Luxembourg, N4, L-1855.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative as a significant institutional investor, T. Rowe Price, has reduced its stake in Globant SA to below 5%, suggesting a less favorable view or a reallocation of capital away from the company.
Negatives
- The filing, being Amendment No. 7 and showing a stake of 4.4%, implies that T. Rowe Price Associates, Inc. has reduced its beneficial ownership in Globant SA to below the 5% threshold, which could be interpreted as a less bullish stance by a significant institutional investor.
Risks
- A reduction in stake by a major institutional investor like T. Rowe Price could signal a perceived increase in risk or a less favorable outlook for Globant SA by that investor.
- Such a reduction might lead to negative market sentiment or increased selling pressure on Globant SA's stock.
Future Outlook
NA
Management Comments
- T. Rowe Price Associates, Inc. certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- T. Rowe Price Associates, Inc. expressly denies beneficial ownership of the securities, stating that the filing of Schedule 13G shall not be construed as an admission of such.
Industry Context
NA
Stakeholder Impact
- Shareholders: The reduction in stake by a major institutional investor could lead to decreased investor confidence and potentially impact the stock price negatively.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/14/2025 | Signature date of the filing by T. Rowe Price Associates, Inc. |
Recommendation
holdThe implied reduction in stake by a major institutional investor like T. Rowe Price suggests a cautious outlook. While not a direct 'sell' signal, it indicates that a significant holder is reducing exposure. For existing investors, this warrants a 'hold' to re-evaluate their position in light of this institutional divestment, and for potential new investors, it suggests caution before initiating a position.
Keywords
Globant SA, T. Rowe Price, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Adviser, GLBT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.